NCT02698358Unknown不适用
Korean Multicenter Registry of EPIC Stent for Iliac Artery Disease: (K-EPIC Registry)
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 68
- 试验地点
- 1
- 主要终点
- Primary patency
研究概览
简要总结
- Prospective, single-arm, multi-center registry study
- A total of 150 subjects with iliac artery disease who meet all inclusion and exclusion criteria will be included.
- Patients will be followed clinically for 12 months after the procedure.
- Duplex ultrasound, CT or catheter-based angiography follow-up according to participating hospital's protocol will be performed at 12 months.
- Presence of stent fracture will be evaluated by plain radiography or fluoroscopy at 12 months.
- Quality of life by standardized questionnaires (at baseline & at 1 & 12 months)
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 19 years of older
- •Symptomatic peripheral artery disease:
- •Moderate or severe claudication (Rutherford category 2 or 3)
- •Critical limb ischemia (Rutherford category 4)
- •Iliac artery lesions with stenosis > 50%
- •Patients with signed informed consent
排除标准
- •Acute critical limb ischemia
- •Severe critical limb ischemia (Rutherford category 5 or 6)
- •Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, cilostazol, or contrast agents
- •In-stent restenosis lesions (Restenosis lesions without previously implanted stents are eligible to the enrollment)
- •Bypass graft lesions
- •Age > 85 years
- •Severe hepatic dysfunction (> 3 times normal reference values)
- •Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
- •LVEF < 40% or clinically overt congestive heart failure
- •Pregnant women or women with potential childbearing
- •Life expectancy <1 year due to comorbidity
- •Untreated proximal inflow disease of aorta or the ipsilateral iliac arteries (more than 50% stenosis or occlusion)
结局指标
主要结局
Primary patency
时间窗: 12 months
Absence of restenosis \>50% based on an imaging study (Duplex ultrasound, CT angiography or catheter angiography) at 12 months
次要结局
- Target lesion revascularization rate(12 months)
- Stent fracture rate(12 months)
- Quality of life by standardized questionnaires(12 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Korean Multicenter Registry of EPIC stent for Iliac Artery Disease: (K-EPIC Registry)KCT0002956Yonsei University Health System, Severance Hospital150
已完成
不适用
Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery DiseaseSymptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)NCT06234280Yonsei University100
Unknown
不适用
Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)NCT03505931Yonsei University100
Unknown
不适用
Korean Multicenter Registry of INNOVA Stent for Femoropopliteal Artery Disease: (K-INNOVA Registry)Femoropopliteal Artery DiseaseNCT02701816Yonsei University150
已完成
不适用
Atrium iCAST Iliac Stent Pivotal StudyPeripheral Vascular DiseaseNCT00593385Atrium Medical Corporation165